The best peptides for healing, with the honest state of the human evidence
This is the most searched peptide category and the one with the widest gap between popularity and proof. BPC-157 and TB-500 are everywhere and neither has an adequately powered human trial. GHK-Cu, which nobody talks about, has the best human data in the group.
Quick answer
| # | Compound | Class | Evidence | Reported range | Status |
|---|---|---|---|---|---|
| 1 | GHK-Cu | Healing & repair | Clinical trials | 1-2 mg | Unapproved |
| 2 | TB-500 | Healing & repair | Preliminary human | 2-5 mg | Research only |
| 3 | ARA-290 | Healing & repair | Clinical trials | 2-4 mg | Research only |
| 4 | BPC-157 | Healing & repair | Animal models only | 200-500 mcg | Research only |
| 5 | KPV | Healing & repair | Animal models only | 200-500 mcg | Research only |
The ranking
The strongest human evidence base in the healing group, nearly all of it dermatological. Controlled trials show measurable collagen stimulation and wound-repair effects topically. The injectable systemic use is far less supported, and that is the use most people searching this page have in mind.
Synthetic thymosin beta-4 with small human trials in dry eye and pressure ulcers. The musculoskeletal claims that drive its popularity rest on animal models. Prohibited in sport.
Material for this compound is sold for laboratory research only. It is not manufactured, tested or labelled for human administration.
An erythropoietin-derived peptide with real human trial data in small-fibre neuropathy. Narrow indication, genuinely studied. Belongs on this list more than most of what usually appears on it.
Material for this compound is sold for laboratory research only. It is not manufactured, tested or labelled for human administration.
The most searched compound in the category. Extensive rodent data across tendon, ligament, muscle and gut. No adequately powered human trial. FDA Category 2. We rank it fourth not because it does not work but because nobody has shown that it does in a person, and three compounds above it have.
Material for this compound is sold for laboratory research only. It is not manufactured, tested or labelled for human administration.
The anti-inflammatory tail of alpha-MSH. Animal models in inflammatory bowel disease are promising. No human data. Included because it is widely stacked with BPC-157 and buyers should know it stands on less.
Material for this compound is sold for laboratory research only. It is not manufactured, tested or labelled for human administration.
What we left out, and why
Head-to-head comparisons
References for the compounds in this guide
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.Int J Mol Sci 2018.PubMed 29986520 · doi:10.3390/ijms19071987
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.Biomed Res Int 2015.PubMed 26236730 · doi:10.1155/2015/648108
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.Am J Sports Med 2026.PubMed 41476424 · doi:10.1177/03635465251357593
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.J Am Acad Orthop Surg Glob Res Rev 2026.PubMed 41490200 · doi:10.5435/JAAOSGlobal-D-25-00236
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med 2026.PubMed 41966639 · doi:10.1007/s40279-026-02437-0
- Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?.Molecules 2025.PubMed 39795193 · doi:10.3390/molecules30010136
- The human tri-peptide GHK and tissue remodeling.J Biomater Sci Polym Ed 2008.PubMed 18644225 · doi:10.1163/156856208784909435
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.Int J Mol Sci 2026.PubMed 42123471 · doi:10.3390/ijms27093890
- The beta-thymosin enigma.Ann N Y Acad Sci 2007.PubMed 17495248 · doi:10.1196/annals.1415.021
- beta-Thymosins.Ann N Y Acad Sci 2007.PubMed 17468232 · doi:10.1196/annals.1415.018
- The platelet cytoskeleton.Thromb Haemost 1993.PubMed 8165606
- [Biomolecules suppressing myelopoiesis].Acta Cient Venez 1992.PubMed 1343739
- Thymosin β4 Promotes Dermal Healing.Vitam Horm 2016.PubMed 27450738 · doi:10.1016/bs.vh.2016.04.005
- The time to develop treatments for diabetic neuropathy.Expert Opin Investig Drugs 2021.PubMed 33423557 · doi:10.1080/13543784.2021.1868433
- ARA 290 for treatment of small fiber neuropathy in sarcoidosis.Expert Opin Investig Drugs 2014.PubMed 24555851 · doi:10.1517/13543784.2014.892072
- Managing fatigue in sarcoidosis - A systematic review of the evidence.Chron Respir Dis 2017.PubMed 27507833 · doi:10.1177/1479972316661926
- Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.Invest Ophthalmol Vis Sci 2017.PubMed 28475703 · doi:10.1167/iovs.16-21291
- Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin.Pharmacol Ther 2015.PubMed 25728128 · doi:10.1016/j.pharmthera.2015.02.005
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.Mol Med 2013.PubMed 24136731 · doi:10.2119/molmed.2013.00122
- Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.Curr Pain Headache Rep 2026.PubMed 42635865 · doi:10.1007/s11916-026-01542-z
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.Mol Med 2015.PubMed 25387363 · doi:10.2119/molmed.2014.00215
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.Cell Tissue Res 2019.PubMed 30915550 · doi:10.1007/s00441-019-03016-8
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.Curr Pharm Des 2018.PubMed 29998800 · doi:10.2174/1381612824666180712110447
- Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance?.Arthroscopy 2025.PubMed 39265666 · doi:10.1016/j.arthro.2024.09.005
Literature retrieved from PubMed on October 16, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.